Kodiak Sciences Market Sentiment

SPY766.30+0.12%QQQ715.10+0.41%BTC/USD79,906.37−0.29%DIA522.70−0.05%GLD370.33+0.68%TLT81.54−0.17%

Premium Services

Kodiak Sciences Inc

KODNASDAQ

Trade with Public

$94.14

4.545.07%

Last update: Oct 27, 10:08 AM

Overview News Earnings Forecast Events Price Targets FinancialsSentimentOwnership Compare Options Stock Report

Kodiak Sciences Market Sentiment - Benzinga

Kodiak Sciences Market Sentiment

Market sentiment signals for Kodiak Sciences (KOD): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▲ 23.6% short float

Options Flow▲ 0.14 P/C ratio

Insider Activity▲ Net Buyer (30d)

Analyst Consensus

Buy

12 analysts

Options Flow (P/C)

0.14

More calls — Bullish

316 calls · 45 puts

Avg Consensus PT

$56

-40.8%

Highest Price Target

$145

+54.0%

LifeSci Capital

Lowest Price Target

-97.9%

Goldman Sachs

Short Interest

23.6%

Declining — Bullish

Insider Activity (30d)

Net Buyer

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Oct 12, 2026	HC Wainwright & Co.	Matthew Caufield—	+33.8%	$96 → $126	Maintained	Buy
Sep 28, 2026	LifeSci Capital	Patrick Dolezal—	+54.0%	$85 → $145	Maintained	Outperform
Sep 28, 2026	UBS	Michael Yee—	+27.5%	$80 → $120	Maintained	Buy
Sep 28, 2026	HC Wainwright & Co.	Matthew Caufield—	+2.0%	$58 → $96	Maintained	Buy
Sep 24, 2026	Goldman Sachs	Andrea Newkirk—	-61.8%	$36	Reinstates	Neutral
Sep 17, 2026	HC Wainwright & Co.	Matthew Caufield—	-38.4%	$58 → $58	Maintained	Buy
Aug 17, 2026	HC Wainwright & Co.	Matthew Caufield—	-38.4%	$58 → $58	Maintained	Buy
Aug 3, 2026	JP Morgan	Anupam Rama—	-29.9%	$56 → $66	Maintained	Overweight
May 11, 2026	Chardan Capital	Daniil Gataulin—	-35.2%	$14 → $61	Upgrade	Neutral→Buy
Mar 27, 2026	UBS	Michael Yee—	-15.0%	$50 → $80	Maintained	Buy
Mar 27, 2026	HC Wainwright & Co.	Matthew Caufield—	-38.4%	$38 → $58	Maintained	Buy
Feb 10, 2026	HC Wainwright & Co.	Matthew Caufield—	-59.6%	$38 → $38	Maintained	Buy
Jan 22, 2026	HC Wainwright & Co.	Matthew Caufield—	-59.6%	$26 → $38	Maintained	Buy
Jan 7, 2026	UBS	Michael Yee—	-46.9%	$50	Initiate	Buy
Nov 17, 2025	Chardan Capital	Daniil Gataulin—	-85.1%	$14 → $14	Maintained	Neutral
Nov 17, 2025	HC Wainwright & Co.	Matthew Caufield—	-72.4%	$24 → $26	Maintained	Buy
Nov 11, 2025	HC Wainwright & Co.	Matthew Caufield—	-74.5%	$5 → $24	Upgrade	Neutral→Buy
Oct 24, 2025	JP Morgan	Anupam Rama—	-74.5%	$15 → $24	Upgrade	Neutral→Overweight
Oct 23, 2025	LifeSci Capital	Patrick Dolezal—	-57.5%	$40	Initiate	Outperform
Oct 6, 2025	Chardan Capital	Daniil Gataulin—	-85.1%	$14	Maintained	Neutral
Sep 25, 2025	Barclays	Gena Wang—	-81.9%	$7 → $17	Upgrade	Underweight→Equal-Weight
Sep 22, 2025	Jefferies	Maury Raycroft—	-84.1%	$15	Initiate	Buy
Aug 18, 2025	HC Wainwright & Co.	Matthew Caufield—	-94.7%	$3 → $5	Maintained	Neutral
Aug 14, 2025	Barclays	Gena Wang—	-92.6%	$4 → $7	Maintained	Underweight
Aug 14, 2025	JP Morgan	Anupam Rama—	-84.1%	$15	Upgrade	Underweight→Neutral